CORRELATION OF SEVERITY OF CORONARY ARTERY DISEASE WITH INSULIN RESISTANCE IN PATIENTS UNDERGOING CORONARY ANGIOGRAM
Main Article Content
Keywords
Coronary artery disease, insulin resistance, HOMA-IR, Gensini score, type 2 diabetes mellitus
Abstract
Diabetes mellitus is recognized as a major risk factor in the development of coronary artery disease (CAD). Insulin resistance (IR), which precedes and accompanies type 2 diabetes mellitus, has been suggested as a predictive marker for CAD severity. However, limited evidence is available linking IR with angiographic severity of CAD in the local population. The objective of this study was to evaluate the correlation between IR, measured using the HOMA-IR index, and the severity of CAD assessed by the modified Gensini score in patients undergoing coronary angiography.
Material & Methods:
This cross-sectional study was conducted at Department of Cardiology, PIC/ Quaid-e-Azam Medical College Bahawalpur, Pakistan over a six-month period. A total of 200 type 2 diabetic patients (age 35–75 years) undergoing coronary angiography were included. Insulin resistance was calculated using HOMA-IR. CAD severity was determined using the modified Gensini score. Chi-square test was applied to assess associations. P-value <0.05 was taken as statistically significant.
Results:
The mean age of the patients was 54.2±9.3 years, with 138 (69%) males and 62 (31%) females. The mean duration of diabetes was 8.1±6.2 years. The mean HOMA-IR score was 3.1±1.2. A significant positive correlation was observed between IR levels and CAD severity as assessed by the modified Gensini score (p<0.01). Patients with higher HOMA-IR scores had more severe, multi-vessel disease.
Conclusion:
Insulin resistance is strongly associated with the severity of coronary artery disease among type 2 diabetic patients. Measurement of HOMA-IR may be considered a useful, simple tool for risk stratification and early identification of patients at risk of severe CAD.
References
2. Ma CX, Ma XN, Guan CH, Li YD, Mauricio D, Fu SB. Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovasc Diabetol. 2022;21:83. doi: 10.1186/s12933-022-01516-6
3. [3] Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin North Am. 2008;37(3):581–601. PMID: 18775354
4. Cho YR, Ann SH, Won KB, et al. Association between insulin resistance, hyperglycemia, and coronary artery disease. Sci Rep. 2019;9:6129. doi: 10.1038/s41598-019-42700-1
5. Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading complexity of CAD. EuroIntervention. 2005;1(2):219–27. Available from: https://eurointervention.pcronline.com/article/the-syntax-score-an-angiographic-tool-grading-the-complexity-of-coronary-artery-disease
6. Kruszelnicka O, Surdacki A, Golay A. Differential associations of angiographic extent and severity of coronary artery disease with asymmetric dimethylarginine but not insulin resistance in non-diabetic men with stable angina. Cardiovasc Diabetol. 2013;12:145. doi: 10.1186/1475-2840-12-145
7. Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic review. Cardiovasc Diabetol. 2018;17:83. doi: 10.1186/s12933-018-0728-6
8. Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for management of hypertension. J Hypertens. 2018;36:1953–2041. doi: 10.1093/eurheartj/ehy339
9. American Diabetes Association. Standards of medical care in diabetes—2019 (Abridged for Primary Care Providers). Clin Diabetes. 2019;37(1):11–34. doi: 10.2337/cd18-0105
10. Jafar TH, Jafary FH, Jessani S, Chaturvedi N. Heart disease epidemic in Pakistan. Am Heart J. 2005;150:221–6. doi: 10.1016/j.ahj.2004.09.025
11. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function. Diabetologia. 1985;28(7):412–9. doi: 10.1007/BF00280883
12. Neeland IJ, Patel RS, Eshtehardi P, et al. Coronary angiographic scoring systems: an evaluation of their equivalence and validity. Am Heart J. 2012;164(4):547–52.e1. doi: 10.1016/j.ahj.2012.07.007
13. Ormazabal V, Nair S, Elfeky O, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17:122. doi: 10.1186/s12933-018-0762-4
14. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 2011;14(5):575–85. doi: 10.1016/j.cmet.2011.07.015
15. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, Bonadonna RC, Muggeo M. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck Study. Diabetes Care. 2007;30(2):318–24. doi: 10.2337/dc06-0919
16. Krishnaswami S, Jose VJ, Joseph G. Lack of correlation between CAD risk factors and severity. Int J Cardiol. 1994;47:37–43. doi: 10.1016/0167-5273(94)90131-7
17. Yayan J. Association of traditional risk factors with coronary artery disease in nonagenarians: the primary role of hypertension. Clin Interv Aging. 2014;9:2003–12. doi: 10.2147/CIA.S74471
18. Leon BM, Maddox TM. Diabetes and cardiovascular disease: mechanisms and treatment. World J Diabetes. 2015;6(13):1246–58. doi: 10.4239/wjd.v6.i13.1246
19. Ko D, et al. Sex differences in modifiable risk factors and severity of coronary artery disease. J Am Heart Assoc. 2017;6(2):e004387. doi: 10.1161/JAHA.116.004387
20. Rubinshtein R, Halon DA, Jaffe R, et al. Relation between obesity and severity of CAD. Am J Cardiol. 2006;97:1277–80. doi: 10.1016/j.amjcard.2005.11.033